Archive · 15 Sep 2025
Jefferies Recommends M&M, Sun Pharma, and More for September
The financial firm Jefferies is recommending specific stocks for investors to buy in September.
They believe that companies like Mahindra & Mahindra, Sun Pharma, Jindal Stainless, TVS Motor, and Mankind Pharma will perform well.
Jefferies bases these recommendations on factors like the growing market for stainless steel, the success of Sun Pharma's specialty portfolio, and Mahindra & Mahindra's expansion in the SUV market.
Overall, the firm expects positive returns from these investments.
Jefferies has a Buy rating on Mahindra & Mahindra, TVS Motor, Jindal Stainless, Sun Pharma, and Mankind Pharma.
M&M expected to have 9% CAGR growth over FY25-28E in tractor sales.
Jefferies views TVS Motor as well-placed, with a Buy rating.
Jindal Stainless has a Buy rating due to its market share and import curbs.
Sun Pharma's specialty portfolio is growing, Jefferies has a Buy rating.
- Who
- Jefferies
- What
- Recommended stocks with a Buy rating.
- When
- September
- Where
- India
- Why
- Based on expected growth and market trends.
- Brokerage Firm
- Jefferies
- Rating
- Buy
- M&M Target Price
- Not specified
- Sun Pharma Target Price
- Rs 2,070
- Jindal Stainless Target Price
- Rs 900
- Mankind Pharma Target Price
- Rs 3,100
Sources
Maruti Suzuki, Bajaj Auto to Ashok Leyland: Is it wise to buy auto stocks amid India-US trade deal, US Fed rate cut buzz
Mercedes expects GST cut to drive ‘best-ever festive season’
Most Mutual Funds pile into Indian auto stocks like Maruti, Hyundai on GST reforms
